ArticleClinical journal of gastroenterology2025
Relapsed refractory immune checkpoint inhibitor-induced colitis treated with tacrolimus and maintained with vedolizumab.
Shohei Igarashi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it